The 2025 Nobel Prize in Physiology or Medicine is awarded to Joel Habener, Svetlana Mojsov, and Jens Juul Holst for their discovery and development of GLP-1based therapeutics, which have revolutionized the treatment of diabetes and obesity worldwide. Well
a bactericidal agent kills them outright
Cardiovascular risk appears to increase in tandem with duration of NSAID use (Conaghan 2012)
Such interactions are particularly critical for narrow-therapeutic-index drugs like warfarin, digoxin, and flecainide, where minor dosage changes can trigger severe adverse effects (86)
GLP-1 medications are essentially injectable imitators of this hormone, offering similar benefits for managing blood sugar levels
For those who prefer simplicity, products like Replenza, Evolv , or Thrive offer a reasonable starting point